Integrative Bioinformatics-Gene Network Approach Reveals Linkage between Estrogenic Endocrine Disruptors and Vascular Remodeling in Peripheral Arterial Disease.

estrogenic endocrine disruptors gene network analysis gene–environment interaction peripheral arterial disease vascular remodeling

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
19 Apr 2024
Historique:
received: 20 03 2024
revised: 16 04 2024
accepted: 17 04 2024
medline: 27 4 2024
pubmed: 27 4 2024
entrez: 27 4 2024
Statut: epublish

Résumé

Vascular diseases, including peripheral arterial disease (PAD), pulmonary arterial hypertension, and atherosclerosis, significantly impact global health due to their intricate relationship with vascular remodeling. This process, characterized by structural alterations in resistance vessels, is a hallmark of heightened vascular resistance seen in these disorders. The influence of environmental estrogenic endocrine disruptors (EEDs) on the vasculature suggests a potential exacerbation of these alterations. Our study employs an integrative approach, combining data mining with bioinformatics, to unravel the interactions between EEDs and vascular remodeling genes in the context of PAD. We explore the molecular dynamics by which EED exposure may alter vascular function in PAD patients. The investigation highlights the profound effect of EEDs on pivotal genes such as ID3, LY6E, FOS, PTP4A1, NAMPT, GADD45A, PDGF-BB, and NFKB, all of which play significant roles in PAD pathophysiology. The insights gained from our study enhance the understanding of genomic alterations induced by EEDs in vascular remodeling processes. Such knowledge is invaluable for developing strategies to prevent and manage vascular diseases, potentially mitigating the impact of harmful environmental pollutants like EEDs on conditions such as PAD.

Identifiants

pubmed: 38674087
pii: ijms25084502
doi: 10.3390/ijms25084502
pii:
doi:

Substances chimiques

Endocrine Disruptors 0
Estrogens 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NSF
ID : 2332021

Auteurs

Vincent Avecilla (V)

Robert Stempel College of Public Health & Social Work, Florida International University, Miami, FL 33199, USA.

Mayur Doke (M)

Diabetes Research Institute, University of Miami, Miami, FL 33136, USA.

Madhumita Das (M)

Department of Biology, Miami Dade College, Miami, FL 33132, USA.

Oscar Alcazar (O)

Diabetes Research Institute, University of Miami, Miami, FL 33136, USA.

Sandeep Appunni (S)

Department of Biochemistry, Government Medical College, Kozhikode 673008, Kerala, India.

Arthur Rech Tondin (A)

Diabetes Research Institute, University of Miami, Miami, FL 33136, USA.

Brandon Watts (B)

Diabetes Research Institute, University of Miami, Miami, FL 33136, USA.

Venkataraghavan Ramamoorthy (V)

Baptist Health South Florida, Miami Gardens, FL 33176, USA.

Muni Rubens (M)

Baptist Health South Florida, Miami Gardens, FL 33176, USA.

Jayanta Kumar Das (JK)

Department of Health and Natural Sciences, Florida Memorial University, Miami Gardens, FL 33054, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH